A new genetic locus for antipsychotic-induced weight gain: A genome-wide study of first-episode psychosis patients using amisulpride (from the OPTiMiSE cohort)

Sophie E. ter Hark, Stephane Jamain, Dick Schijven, Bochao D. Lin, Mark K. Bakker, Anne Boland-Auge, Jean-Francois Deleuze, Rejane Troudet, Anil K. Malhotra, Sinan Guloksuz, Christiaan H. Vinkers, Bjorn H. Ebdrup, Rene S. Kahn, Marion Leboyer, Jurjen J. Luykx*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number0269881120907972
Pages (from-to)524-531
Number of pages8
JournalJournal of Psychopharmacology
Volume34
Issue number5
DOIs
Publication statusPublished - May 2020

Keywords

  • Pharmacogenetics
  • antipsychotics
  • body mass index
  • amisulpride-induced weight gain
  • schizophrenia
  • GWAS
  • SELENOPROTEIN-P
  • GROWTH-HORMONE
  • SCHIZOPHRENIA
  • ASSOCIATION
  • INSULIN
  • MEDICATIONS
  • CLOZAPINE
  • VARIANTS
  • PROFILES
  • SEPP1

Cite this